Dermatology - Clinical Pharmacology News & Articles

281 A Decade of Experience with Injectable Poly-L-Lactic Acid: A Focus on Safety Dermatologic Surgery, February 12, 2013    Clinical Article

282 Refractory cutaneous angiosarcoma successfully treated with sunitinib British Journal of Dermatology, February 11, 2013    Clinical Article

283 Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis Journal of the European Academy of Dermatology and Venereology, February 11, 2013    Clinical Article

284 Topical treatments for cutaneous warts: an update Expert Review of Dermatology, February 11, 2013    Review Article    Clinical Article

285 Onychomycosis Does Not Always Require Systemic Treatment for Cure: A Trial Using Topical Therapy Pediatric Dermatology, February 11, 2013    Clinical Article

286 Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-kB and STAT3 in human keratinocytes Pharmacological Research , February 11, 2013    Review Article

287 Trichodysplasia spinulosa: A benign adnexal proliferation with follicular differentiation associated with polyomavirus Australasian Journal of Dermatology, February 11, 2013    Clinical Article

288 Treatment of Infantile Hemangiomas with Sirolimus in a Patient with PHACE Syndrome Pediatric Dermatology, February 11, 2013

289 Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result Dermatologic Therapy, February 11, 2013

290 Impetigo-Like Tinea Faciei Around the Nostrils Caused by Arthroderma vanbreuseghemii Identified Using Polymerase Chain Reaction-Based Sequencing of Crusts Pediatric Dermatology, February 11, 2013

291 Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis Journal of the European Academy of Dermatology and Venereology, February 8, 2013    Clinical Article

292 Acne treatment by methyl aminolevulinate photodynamic therapy with red light vs. intense pulsed light International Journal of Dermatology, February 8, 2013    Clinical Article

293 Botulinum Toxin A for the Treatment of Keloids Skin Pharmacology and Physiology, February 8, 2013    Clinical Article

294 Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis New England Journal of Medicine, February 8, 2013    Clinical Article

295 Lichen planus pemphigoides: four new cases and a review of the literature International Journal of Dermatology, February 8, 2013

296 HIV-Related CD8+ Cutaneous Pseudolymphoma: Efficacy of Methotrexate Dermatology, February 8, 2013

297 A randomised Phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis British Journal of Dermatology, February 7, 2013    Clinical Article

298 Efficacy and Patient-Reported Outcomes of a New Mometasone Cream Treating Atopic Eczema Skin Pharmacology and Physiology, February 7, 2013    Clinical Article

299 Use of alpha-tocopherol esters for topical vitamin E treatment: evaluation of their skin permeation and metabolism Journal of Pharmacy and Pharmacology, February 7, 2013    Review Article

300 Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study International Journal of Dermatology, February 7, 2013    Clinical Article

1 Isotretinoin 5 mg daily for low-grade adult acne vulgaris - a placebo-controlled, randomized double-blind study Journal of the European Academy of Dermatology and Venereology, April 29, 2013

2 Effective treatment of uremic pruritus and acquired perforating dermatosis with amitriptyline Australasian Journal of Dermatology, February 22, 2013

3 A randomized, double-blind, placebo and active-controlled, half-head study to evaluate the effects of platelet rich plasma on alopecia areata British Journal of Dermatology, April 23, 2013

4 Amiodarone and the risk of cancer Cancer, April 18, 2013

5 Novel Targets in the Treatment of Advanced Melanoma: New First-Line Treatment Options Annals of Pharmacotherapy, April 9, 2013

6 Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses JAMA Dermatology, March 25, 2013

7 Serum prolidase activity in psoriasis patients Archives of Dermatological Research, April 10, 2013

8 Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion Arthritis Research & Therapy, April 19, 2013

9 A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment Indian Journal of Dermatology, April 22, 2013    Free full text

10 Pimecrolimus for psoriasis Expert Opinion on Pharmacotherapy, April 8, 2013

11 Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face study Journal of Dermatological Treatment , April 4, 2013

12 Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University Journal of the American Academy of Dermatology, February 25, 2013

13 Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study Journal of Dermatological Treatment , April 5, 2013

14 Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis Clinical, Cosmetic and Investigational Dermatology, March 15, 2013    Free full text

15 Rapid relief of intertrigo-associated pruritus due to Candida albicans with isoconazole nitrate and diflucortolone valerate combination therapy Mycoses, April 12, 2013

16 Carboplatin, paclitaxel and sorafenib in advanced melanoma -what have we learned? Translational Cancer Research , April 3, 2013    Free full text

17 Topical treatments for chronic plaque psoriasis Cochrane Reviews, April 1, 2013

18 Topical Retinoids in Oral Lichen Planus Treatment: An Overview Dermatology, March 29, 2013    Review Article

19 Oxidative stress and psoriasis: the effect of antitumour necrosis factor- inhibitor treatment British Journal of Dermatology, April 26, 2013

20 Ingenol Mebutate Gel 0.015% and 0.05%: In Actinic Keratosis Drugs, February 1, 2013